The Role of Pharmacogenomics in Personalized Medicine

/Home/Biologics Delivery - Protein Synthesis/Biologics Market Research - Protein Synthesis

The Role of Pharmacogenomics in Personalized Medicine
Decision Resources
June 30, 2006
28 Pages
Pub ID: DECR1320800
US $1,900.00 PDF E-mail From Publisher
Abstract
The pharmaceutical industry is very gradually moving away from the blockbuster model of drug development to a model whereby medicines are designed to treat the specific patient, not the population as a whole. This trend is known as personalized medicine. Pharmacogenomics, which determines how genomic variations in people modify the behavior of drugs, will facilitate the development of personalized medicine. In this report, we examine how the use of pharmacogenomics will affect today?s drug development strategies. We discuss many of the economic considerations now facing the industry in deciding whether or not to embrace pharmacogenomics in personalized medicine. Our Spectrum Expert Commentary addresses the attitudes of Americans on these issues.